Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TT-816 |
Trade Name | |
Synonyms | TT816|TT 816 |
Drug Descriptions |
TT-816 is an antagonist of the cannabinoid receptor CB2R, which potentially leads to enhanced antitumor immune response and inhibition of tumor cell proliferation (Journal for ImmunoTherapy of Cancer 2022;10). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TT-816 | TT-816 | 0 | 1 |
TT-816 + unspecified PD-1 antibody | TT-816 unspecified PD-1 antibody | 0 | 1 |